BBB	Blood–brain barrier
BDNF	Brain-derived neurotropic factor
cAMP	Cyclic adenosine monophosphate
CAR	Chimeric antigen receptor
CNS	Central nervous system
COX	Cyclooxygenase
CT	Chemotherapy
CTLA-4	Cytotoxic T-lymphocyte-associated protein 4
GBM	Glioblastoma
GM-CSF	Granulocyte-macrophage colony-stimulating factor
HAVCR2	Hepatitis A virus cellular receptor 2
HGG	High-grade glioma
HT	Hyperthermia therapy
IDO1	Indoleamine 2,3-dioxygenase 1
IFN	Interferon
IL	Interleukin
KD	Ketogenic diet
LAG-3	Lymphocyte activation gene 3
LLG	Low-grade glioma
MAP	Mitogen-activated protein
M-CSF	Macrophage colony-stimulating factor
MHT	Magnetic hyperthermia therapy
MRI	Magnetic Resonance Imaging
mRNA	Messenger Ribonucleic Acid
NF-1	Neurofibromatosis type 1
NGF	Neuronal growth factor
NPs	Nanoparticles
OCT	Optical coherence tomography
ONGs	Optic nerve gliomas
OPGs	Optic pathway gliomas
PBCT	Proton boron capture therapy
PD-1	Programmed cell death protein 1
PDGFR	Platelet-derived growth factor receptor
PD-L1	Programmed death-ligand 1
PDT	Photodynamic therapy
PFS	Progression free survival
PT	Proton therapy
rGBM	Recurrent glioblastoma
RGCs	Retinal ganglion cells
RNFL	Retinal nerve fiber layer
RT	Radiotherapy
siRNA	Small interfering RNA
TAMs	Tumor-associated macrophages
TCR	T cell receptor
TGF	Transforming growth factor
TMZ	Temozolamide
TNF	Tumor necrosis factor
TNFR	Tumor necrosis factor receptor
TTFields	Tumor-treating fields
VEGF	Vascular endothelial growth factor
VEPs	Visual evoked potentials
VLA-4	Very late antigen 4
WHO	World Health Organization